Sanjay Bhanot

This inventor holds 62 USPTO granted patents and 25 published patent applications, plus 5 CIPO patents and 23 EPO patents, primarily in Gene Expression Modulation (CPC class C12N). Top assignees: Isis Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Regulus Therapeutics Inc.. Active years: 2007-2022.

USPTO Granted Patents = 62 (Patent Applications = 25)

% Patents Active = 37.1

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 23 (Patent Applications = 36)

Average Co-Inventor Count = 3.6

ph-index = 14

Forward Citations = 797(Granted Patents)

Forward Citations (Not Self Cited) = 749(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Encinitas, CA (US) (2007)
Carlsbad, CA (US) (2008 - 2022)

Company Filing History:

48 out of 1,035

Isis Pharmaceuticals, Inc.

patents

12 out of 286

Ionis Pharmaceuticals, Inc.

patents

2 out of 63

Regulus Therapeutics Inc.

patents

Years Active: 2007-2022

Loading Chart...

Areas of Expertise:

Hypercholesterolemia

Gene Expression

DGAT2

GCCR

PTP1B

FGFR4

miR-122A

ApoB

SGLT2

Acetyl-CoA Carboxylases

eIF4E-BP1

Glucose-6-Phosphatase

62 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11530410 - Methods for treating hypercholesterolemia (2022-12-20),

2. 11312964 - Compositions and methods for modulating growth hormone receptor expression (2022-04-26),

3. 11312962 - Modulators of diacyglycerol acyltransferase 2 (DGAT2) (2022-04-26),

4. 10858657 - Methods for treating hypercholesterolemia (2020-12-08),

5. 10793862 - Compositions and methods for modulating growth hormone receptor expression (2020-10-06),

6. RE48060 - Antisense modulation of PTP1B expression (2020-06-22),

7. 9994855 - Compositions and methods for modulating growth hormone receptor expression (2018-06-12),

8. 9994842 - Methods for use in modulating miR-122A (2018-06-12),

9. 9650636 - Methods for treating hypercholesterolemia (2017-05-16),

10. 9617540 - Compounds and methods for modulating gene expression (2017-04-11),

11. 9567587 - Antisense modulation of GCCR expression (2017-02-14),

12. 9404114 - Antisense modulation of GCGR expression (2016-08-02),

13. 9404113 - Antisense modulation of PTP1B expression (2016-08-02),

14. 9045754 - Short antisense compounds with gapmer configuration (2015-06-02),

15. 9034842 - Antisense modulation of PTP1B expression (2015-05-19),

Title: The Innovative Journey of Sanjay Bhanot

Introduction: Sanjay Bhanot, a visionary inventor based in Carlsbad, CA (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Sanjay Bhanot holds several patents in the areas of artificial intelligence, machine learning, and robotics. His most recent patent involves a cutting-edge algorithm for autonomous drones that can revolutionize the delivery industry.

Career Highlights: With a background in computer science and engineering, Sanjay Bhanot has a successful track record of developing innovative solutions for complex technological challenges. Throughout his career, he has worked with leading tech companies to bring his ideas to life.

Collaborations: Sanjay Bhanot has collaborated with top research institutions and universities to further advance his inventions. His collaborative efforts have led to the development of groundbreaking technologies that have the potential to shape the future of various industries.

Conclusion: Sanjay Bhanot's passion for innovation and his relentless pursuit of technological advancement have established him as a prominent figure in the world of inventors. His dedication to pushing the boundaries of what is possible continues to inspire the next generation of innovators.